Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

For something so small, the prostate can cause big problems. This gland, which is roughly the size of a walnut, is an essential part of a man's urinary and reproductive systems. But it's not uncommon ...

Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study. “Overtreatment of ...

As temperatures drop, a trend of increased prostate-related problems among men over 60 has been observed by experts. Benign prostatic hyperplasia (BPH), also called prostate gland enlargement, is a ...

Ask a urologist and they’ll tell you the prostate has two main functions: producing fluid that forms part of semen, and – less officially – keeping urologists in business. That’s a lot of ...

Because AGA typically presents decades before the first symptoms of BPH, Arias-Santiago and colleagues suggest that early-onset AGA may be a useful marker for BPH risk later in life. To test this ...

Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is ...

The prostate gland has become another major concern of many Nigerian men today, after hypertension, heart and colon questions. The gland is either inflamed, enlarged or cancerous in many cases. Among ...

CHICAGO (Reuters) - A third pivotal trial of Amgen Inc's denosumab found that it significantly delayed the likelihood of suffering fractures and other bone complications in men with advanced prostate ...